Intellia Therapeutics, Inc. (NTLA): $71.36

-0.64 (-0.89%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add NTLA to Watchlist
Sign Up

Industry: Biotech


Ranked

of 492

in industry

Intellia Therapeutics Inc (NTLA) Price Targets From Analysts

Use the tables below to see what analysts covering Intellia Therapeutics Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
13 $111 $24 $78.46 $72 8.97%

The Trend in the Analyst Price Target


NTLA's average price target has moved up $50.76 over the prior 209 days.

NTLA reports an average of 10.59% for its upside potential over the past 326 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-04-25 13 111.0 24 78.46 78.29 0.22%
2021-04-17 13 111.0 24 78.46 70.45 11.37%
2021-04-10 13 111.0 24 78.46 70.64 11.07%
2021-04-03 13 111.0 24 78.46 80.06 -2%
2021-03-20 13 111.0 24 78.46 65.70 19.42%
2021-03-13 13 111.0 24 78.46 65.52 19.75%
2021-03-06 13 111.0 24 78.46 51.81 51.44%
2021-02-27 12 116.0 24 78.50 60.46 29.84%
2021-02-20 12 109.0 24 74.58 72.37 3.05%
2021-02-13 12 109.0 24 74.58 68.28 9.23%
2021-02-06 12 109.0 24 72.29 69.21 4.45%
2021-01-30 13 109.0 22 68.42 62.62 9.26%
2021-01-23 13 109.0 22 68.42 74.36 -7.99%
2021-01-16 13 109.0 22 66.88 81.89 -18.33%
2021-01-09 13 109.0 22 66.88 78.36 -14.65%
2021-01-02 13 66.0 22 44.19 54.40 -18.77%
2020-12-26 13 66.0 22 44.19 62.14 -28.89%
2020-12-19 13 64.0 22 39.50 55.41 -28.71%
2020-12-10 13 60.0 22 38.58 55.86 -30.93%
2020-12-07 13 57.5 22 35.96 46.59 -22.82%
2020-11-28 13 57.5 22 35.96 39.38 -8.68%
2020-11-13 13 57.5 22 35.96 33.23 8.22%
2020-11-05 13 57.5 22 35.58 28.48 24.93%
2020-10-26 13 57.5 21 32.81 24.50 33.92%
2020-09-28 10 46.0 16 27.70 21.22 30.54%
2020-09-17 9 37.0 16 25.67 22.45 14.34%
2020-08-17 8 37.0 16 24.75 20.85 18.71%
2020-08-15 10 57.5 16 30.15 19.89 51.58%
2020-08-06 10 57.5 16 28.85 19.99 44.32%
2020-07-21 10 57.5 16 28.65 20.96 36.69%
2020-06-14 11 57.5 16 28.05 19.34 45.04%
2020-06-03 10 57.5 16 28.65 22.33 28.3%
2020-06-03 11 57.5 16 28.05 22.33 25.62%

NTLA Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.61 2 7 5 0 0 14

The Trend in the Broker Recommendations


Over the past 151 days, NTLA's average broker recommendation rating worsened by 0.4.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • NTLA has a lower variance in analysts' estimates than 3.2% of all US stocks.
  • The number of analysts covering the stock of NTLA is greater than 91.22% of Pharmaceutical Products stocks.
  • The upside potential (average analyst target price relative to current price) of NTLA is greater than 9.66% of Pharmaceutical Products stocks.
  • NTLA has a greater average analyst price target than 88.43% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, PCRX, DNLI and ARWR are the three stocks most similar to Intellia Therapeutics Inc regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding NTLA using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.726 seconds.